APA (7th ed.) Citation

J, A., F, G., D, S., C, J., V, U., T, H., . . . RL, V. (2023). IGF2 prevents dopaminergic neuronal loss and decreases intracellular alpha-synuclein accumulation in Parkinson's disease models. Cell death discovery, 9(1), 438. https://doi.org/10.1038/s41420-023-01734-1

Chicago Style (17th ed.) Citation

J, Arcos, et al. "IGF2 Prevents Dopaminergic Neuronal Loss and Decreases Intracellular Alpha-synuclein Accumulation in Parkinson's Disease Models." Cell Death Discovery 9, no. 1 (2023): 438. https://doi.org/10.1038/s41420-023-01734-1.

MLA (9th ed.) Citation

J, Arcos, et al. "IGF2 Prevents Dopaminergic Neuronal Loss and Decreases Intracellular Alpha-synuclein Accumulation in Parkinson's Disease Models." Cell Death Discovery, vol. 9, no. 1, 2023, p. 438, https://doi.org/10.1038/s41420-023-01734-1.